Unlike ALL, where Ig/TCR rearrangements are readily identified in most patients [17, 18], developing patient-specific, DNA-based quantitative PCR MRD (qPCR-MRD) assays in HR-NB and EWS has been limited by the absence of readily identifiable, tumour-specific targets. Here, EWSR1 is linked to acute lymphoblastic leukemia.